P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. (23rd June 2022) - Sims, M.; Ward, G.; Zhang, Z.; Jueliger, S.; Davis, M.; Boxall, A.; Taylor, J.; Biondo, A.; Lyons, J.; Smyth, T.